CIT Upholds Applikon's Win In Bioreactor Duty Fight

Law360, New York (April 19, 2012, 3:07 PM EDT) -- The U.S. Court of International Trade has upheld its decision not to level duties on Applikon Biotechnology Inc.'s bioreactor systems, despite claims from the U.S. that the court misclassified the imports and Applikon should have paid duties, according to a slip opinion released Wednesday.

Judge R. Kenton Musgrave on March 28 found against the government, which had requested a rehearing after an earlier finding by the court placed the duties on bioreactor systems made by the Dutch company under subheading 8479.82 of the Harmonized Tariff Schedule...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.